Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CONDITIONINIG REGIMEN IN PATIENTS WITH IDIOPATHIC MYELOFIBROSIS: THE G.I.T.M.O. EXPERIENCE AND REVIEW OF THE LITERATURE

    Francesca Patriarca, Andrea Bacigalupo, Alessandra Sperotto, Miriam Isola, Maria Teresa Van Lint, Anna Paola Iori, Paolo Di Bartolomeo, Maurizio Musso, Pietro Pioltelli, Giuseppe Visani, Pasquale Iacopino, Renato Fanin, Alberto Bosi
    e2010010
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.010
    1571
    PDF: 815
    HTML: 771
  • IRON CHELATION THERAPY WITH DEFERASIROX IN THE MANAGEMENT OF IRON OVERLOAD IN PRIMARY MYELOFIBROSIS

    Elena Maria Elli, Angelo Belotti, Andrea Aroldi, Matteo Parma, Pietro Pioltelli, Enrico Maria Pogliani
    e2014042
    2014-05-30
    https://doi.org/10.4084/mjhid.2014.042
    2200
    PDF: 1181
    HTML: 2016
  • IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

    Federica Sorà, Patrizia Chiusolo, Francesco autore, Sabrina Giammarco, luca laurenti, elisabetta metafuni, idanna innocenti, eugenio galli, andrea bacigalupo, simona sica
    e2021062
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.062
    1295
    PDF: 511
    HTML: 195
  • Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia

    Tathagata Chatterjee, Srishti Gupta, Ajay Sharma, Sanjeevan Sharma, Devika Gupta
    e2013042
    2013-06-04
    https://doi.org/10.4084/mjhid.2013.042
    3312
    PDF: 997
    HTML: 3166
    flowcytometric result of peripheral blood sample: 194
  • CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH

    Lisa Pieri, Paola Guglielmelli, Alessandro Maria Vannucchi
    e2010017
    2010-06-18
    https://doi.org/10.4084/mjhid.2010.017
    1750
    PDF: 766
    HTML: 2349
  • LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT

    Fabian Herrera
    e2024039
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.039
    1538
    PDF: 1049
    HTML: 132
  • BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

    Giuseppe Leone, Eligio Pizzigallo
    e2015057
    2015-10-12
    https://doi.org/10.4084/mjhid.2015.057
    5039
    PDF: 2028
    HTML: 8698
  • DETECTION OF CALR MUTATIONS USING HIGH RESOLUTION MELTING CURVE ANALYSIS (HRM-A); APPLICATION ON A LARGE COHORT OF GREEK ET AND MF PATIENTS

    Andreas Giannopoulos, Niki Rougkala, Theodoros Loupis, Marina Mantzourani, Nora-Athina Viniou, Eleni Variami, Theodoros Vassilakopoulos, George Dryllis, Ioannis Kotsianidis, Theodora Gougopoulou, Marianna Politou, Konstantinos Konstantopoulos, George Vassilopoulos
    e2019009
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.009
    3142
    PDF: 1239
    HTML: 555
  • THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

    Elvira Pelosi, Dr. Germana Castelli, Ugo Testa
    e2022080
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.080
    1587
    PDF: 1215
    HTML: 538
  • Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center

    Muruvvet Seda Aydin, Gulten Korkmaz, Merve Pamukcuoglu, Hatice Rahmet Guner, Funda Ceran, Simten Dagdas, Gulsum Ozet
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.044
    280
    PDF: 351
    HTML: 61
  • THE SPECTRUM OF HYPEREOSINOPHILIA AND ASSOCIATED CLONAL DISORDERS – A REAL WORLD DATA FROM A TROPICAL SETTING.

    Sreejesh Sreedharanunni, Neelam Varma, Man Updesh Singh Sachdeva, Shano Naseem, Pankaj Malhotra, Deepak Bansal, Amita Trehan, Subhash Varma
    e2018052
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.052
    1955
    PDF: 982
    HTML: 582
  • RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES

    Julie Schanz, Friederike Braulke, Detlef Haase
    e2015034
    2015-04-23
    https://doi.org/10.4084/mjhid.2015.034
    3894
    PDF: 1708
    HTML: 11791
    Figures Haase: 227
  • COMPARATIVE EVALUATION OF BONE MARROW ASPIRATE WITH TREPHINE BIOPSY IN HEMATOLOGICAL DISORDERS AND DETERMINATION OF OPTIMUM TREPHINE LENGTH IN LYMPHOMA INFILTRATION

    Surbhi Goyal, Usha Rani Singh, Usha Rusia
    e2014002
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.002
    2082
    PDF: 1095
    HTML: 51856
  • THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association

    Katia Paciaroni, Selenia Campagna, Nicoletta Villiva', Enrico Maffini, Francesca Celesti, Attilio Tordi, Mariangela Lombardi, Giulia Dragonetti, Tommaso Caravita di Toritto
    e2025023
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.023
    1124
    PDF: 1242
    HTML: 117
  • Ph-negative chronic myeloproliferative neoplasm (primary myelofibrosis)– as one of the reasons of the Budd-Chiari syndrome.

    Maria Dmitrievna Sanatko
    e2012047
    2012-06-30
    https://doi.org/10.4084/mjhid.2012.047
    2482
    PDF: 890
    HTML: 703
    Untitled: 241
  • Lung Clear “Sugar” Cell Tumor and Jak V617f Positive Essential Thrombocythemia: A simple Co?nc?dence?

    Volkan Yazak, Gokhan Sargin, Irfan Yavasoglu, Gurhan Kadikoylu, Canten Tataroglu, Gokay Bozkurt, Zahit Bolaman
    e2013021
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.021
    1338
    PDF: 735
    HTML: 2640
  • Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission

    Beatrice Borsellino, Arianna Savi, Maria Rosaria Pascale, Elisa Meddi, Antonio Cristiano, TIZIANA OTTONE, Maria Cristina Rapanotti, Mariadomenica Divona, SERENA TRAVAGLINI, Enrico Attardi, Elisa Buzzatti, Francesco Buccisano, Maria Teresa Voso
    e2022058
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.058
    1749
    PDF: 816
    HTML: 298
  • HYDROXYCARBAMINE: FROM AN OLD DRUG USED IN MALIGNANT HEMOPATHIES TO A CURRENT STANDARD IN SICKLE CELL DISEASE

    Giovanna Cannas, Solene Poutrel, Xavier Thomas
    e2017015
    2017-02-15
    https://doi.org/10.4084/mjhid.2017.015
    4024
    PDF: 1206
    HTML: 1829
  • Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy

    Antonella Vaccarino, Irene Dogliotti, Fabio Marletto, Andrea Demarchi, Mario Bazzan
    e2016050
    2016-10-20
    https://doi.org/10.4084/mjhid.2016.050
    2886
    PDF: 787
    HTML: 1303
    Blood Count trend before and during lenalidomide treatment: 193
    Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 203
  • EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome

    Cumali Yalçın, Bedrettin Orhan, Tuba Ersal, Mümin Şentürk, Vildan Özkocaman, Halis Akalın, Fahir Özkalemkaş
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.032
    978
    PDF: 707
    HTML: 172
  • THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone

    George J Kontoghiorghes, Marios Kleanthous, Christina N. Kontoghiorghe
    e2020011
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.011
    2493
    PDF: 1626
    HTML: 696
  • Calreticulin mutation survey by high resolution melting method associated with unique presentations in essential thrombocythemic patients CALR mutation survey by HRM in ET patients

    Yi-Chang Liu, Ching-Ping Lee, Tsung-Jang Yeh, Yuh-Ching Gau, Chieh-Yu Hsieh, Ya-Lun Ke, Jeng-Shiun Du, Ming-Hui Lin, Hui-Ching Wang, Shih-Hao Tang, Shih-Feng Cho, Jui-Feng Hsu, Samuel Yien Hsiao, Chin-Mu Hsu, Hui-Hua Hsiao
    e2020022
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.022
    1342
    PDF: 759
    HTML: 531
  • THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis

    ANTONIO LEONE, SILVIA MACAGNINO, GIULIA D'AMBRA, DANIELE PERLA
    e2021056
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.056
    1609
    PDF: 581
    HTML: 869
  • VIRAL CIRRHOSIS: AN OVERVIEW OF HAEMOSTATIC ALTERATIONS AND CLINICAL CONSEQUENCES

    Francesca Romana Ponziani, Valerio De Stefano, Antonio Gasbarrini
    e2009033
    2009-12-29
    https://doi.org/10.4084/mjhid.2009.033
    2709
    PDF: 534
    HTML: 3600
  • IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy

    İbrahim Halil Açar, Sebnem Izmir Güner , Muzeyyen Aslaner Ak, Mesut Gocer, Erman Ozturk , Figen Atalay, Gulden Sincan , Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Emine Gulturk , Nazli Demir, Ali Dogan, Yildiz Ipek, Birol Guvenc
    e2022074
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.074
    1776
    PDF: 829
    HTML: 226
  • CMV Reactivations During and after Letermovir Prophylaxis In Allogeneic Hematopoietic Stem Cell Transplantation: a Single-Center Experience.

    Edoardo Olivari
    e2025079
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.079
    499
    PDF: 230
    Html: 91
  • THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies

    Emine Atli, Rasime Kalkan, Cisem Mail, Damla Eker, Ufuk Demirci, Selma Demir, Sinem Yalcintepe, Hakki Onur Kirkizlar, Engin Atli, Hakan Gurkan, Ahmet Muzaffer Demir
    e2021013
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.013
    1958
    PDF: 589
    HTML: 360
  • MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS

    Mrinalini kotru, Deepti Mutereja, Abhishek Purohit, Seema Tyagi, Manoranjan Mahapatra, Renu Saxena, Hara Prasad Pati
    e2016049
    2016-10-17
    https://doi.org/10.4084/mjhid.2016.049
    3367
    PDF: 741
    HTML: 763
    Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 199
    Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 202
    Table : Distribution of the sites of bleeding and their causes: 196
  • DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

    Sabina Chiaretti, Gina Zini, Renato Bassan
    e2014073
    2014-10-24
    https://doi.org/10.4084/mjhid.2014.073
    9274
    PDF: 6177
    HTML: 88040
    Fig.1b: 210
    Fig.1c: 216
    Fig.2a: 201
    Fig.2b: 195
    Fig.4: 222
    Fig.2c: 200
    Fig.3: 202
    Tab.1: 254
    Tab.2: 233
    Tab.3: 213
    Tab.4: 248
    Fig1a: 210
  • THALASSAEMIA INTERMEDIA : AN UPDATE

    Ali Taher, Khaled M. Musallam, Maria Domenica Cappellini
    e2009004
    2009-08-17
    1108
    PDF: 457
    HTML: 9461
  • Cytokine release syndrome after haploidentical transplantation is associated with improved survival without increasing transplant-related mortality

    Daniele Avenoso, Natalia Difrancesco, Enrico Morello, Gabriele Magliano, Mirko Farina, Vera Radici, Simone Bernardi, Alessandro Leoni, Federica Re, Shreyas Hanmantgad, Domenico Russo, Michele Malagola
    e2026059
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.059
    151
    PDF: 131
    HTML: 225
  • Myeloid neoplasms with isolated isochromosome 17q: a yet to be defined entity

    Eleftheria Lamprianidou, Chryssoula Kordella, Menelaos Papoutselis, Zoi Bezyrgiannidou, Evangelia Nakou, Spyros Papamichos, Emmanouil Spanoudakis, Andreas Giannopoulos, Katerina Zoi, Ioannis Kotsianidis
    e2017066
    2017-11-01
    https://doi.org/10.4084/mjhid.2017.066
    2359
    PDF: 806
    HTML: 1239
1 - 32 of 32 items
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.